Genèse Labs France Introduces Rèluma HA Filler to International Markets
- EG BIO
- Jan 30, 2025
- 1 min read
Introducing a new hyaluronic acid filler line for international markets
In January 2025, Rèluma HA Filler, a new hyaluronic acid filler line developed by Genèse Labs France, was officially launched and added to EG Bio Co., Ltd.’s global distribution portfolio.
Rèluma HA Filler was introduced as part of Genèse Labs France’s expanding injectable portfolio, designed for professional aesthetic applications and structured international market entry. The product line reflects a focus on quality standards, portfolio consistency, and alignment with global distributor requirements.
Following the launch, EG Bio began supporting the international distribution and market development of Rèluma HA Filler through its established B2B network. This cooperation enables clear brand positioning, reliable supply, and long-term market planning for distribution partners across multiple regions.
The addition of Rèluma HA Filler further strengthens the collaboration between Genèse Labs France and EG Bio, combining product development expertise with structured global distribution capabilities to support sustainable international growth.
About EG Bio
EG Bio Co., Ltd. is a global B2B supplier and distribution partner specializing in professional aesthetic products. The company works with selected international brands and manufacturers to support structured global distribution, market development, and long-term partnerships across multiple regions.
EG Bio focuses on exclusive distribution models, portfolio expansion, and international market access, providing distributors and professional partners with reliable supply, clear positioning, and sustainable growth opportunities.
About Genèse Labs France
Genèse Labs France is a France-based company focused on the development and management of professional aesthetic and dermocosmetic product portfolios. The company emphasizes regulatory alignment, quality standards, and long-term brand development through structured international partnerships.
Comments